Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 48,069 | 49,888 | 45,508 | 46,465 | 45,483 |
| Accounts receivable | -35,369 | 16,110 | 88,523 | -33,865 | -28,561 |
| Other Working Capital | -88,550 | -94,144 | 84,808 | 1,585 | -159,911 |
| Other Operating Activity | 245,766 | 172,145 | 111,426 | 225,510 | 212,921 |
| Operating Cash Flow | $169,916 | $143,999 | $330,265 | $239,695 | $69,932 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34,942 | -13,501 | -17,970 | -29,589 | -25,100 |
| Net Acquisitions | N/A | N/A | 0 | -24,487 | -3,423 |
| Purchase Of Investment | -6,250 | -8,196 | 17,780 | -41,952 | -13,357 |
| Sale Of Investment | 15,098 | 4,824 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -3,130 | -5,237 | -3,217 | -2,520 | -2,802 |
| Other Investing Activity | -437 | 0 | 0 | -1,064 | 1,064 |
| Investing Cash Flow | $-29,661 | $-22,110 | $-3,407 | $-99,612 | $-43,618 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 55,000 | 200,000 | 260,000 | 165,000 |
| Debt Repayment | -231,000 | -175,000 | -401,000 | -183,000 | -86,009 |
| Common Stock Issued | 17,588 | 1,026 | 22,070 | 1,815 | 18,688 |
| Dividend Paid | -56,654 | -56,511 | -56,483 | -56,408 | -56,150 |
| Other Financing Activity | -46,734 | 227 | -955 | -4,015 | -40,765 |
| Financing Cash Flow | $-316,800 | $-175,258 | $-236,368 | $18,392 | $764 |
| Exchange Rate Effect | 10,996 | 11,627 | 19,805 | -9,709 | 4,863 |
| Beginning Cash Position | 421,414 | 463,156 | 352,861 | 204,095 | 172,154 |
| End Cash Position | 255,865 | 421,414 | 463,156 | 352,861 | 204,095 |
| Net Cash Flow | $-176,545 | $-53,369 | $90,490 | $158,475 | $27,078 |
| Free Cash Flow | |||||
| Operating Cash Flow | 169,916 | 143,999 | 330,265 | 239,695 | 69,932 |
| Capital Expenditure | -38,072 | -18,738 | -21,187 | -32,109 | -27,902 |
| Free Cash Flow | 131,844 | 125,261 | 309,078 | 207,586 | 42,030 |